News & Updates

Sleep disturbance appears to be common among individuals with overactive bladder (OAB), regardless of treatment, as reported in a study.

Focal ablative therapy may be used as an alternative treatment for older or comorbid patients with prostate cancer who are not fit or willing to undergo radical treatment, suggests a study.

The oral selective pan-FGFR tyrosine kinase inhibitor (TKI) erdafitinib demonstrated a survival advantage over chemotherapy, extending multiple efficacy endpoints in individuals with advanced or metastatic urothelial carcinoma (mUC) with FGFR alterations (FGFRalt) after previous anti-PD-(L)1 treatment, findings from the confirmatory phase III THOR trial have shown.

Patients undergoing more extensive lymph node sampling during surgery for a suspected malignant paediatric renal tumour do not appear to have a higher likelihood of experiencing clinically significant complications, reveals a study.